Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.

Zhen Yu WongJia Hong KohMark MuthiahBenjamin KohElden Yen Hng OngChristen En Ya OngKai Qi OuWen Hui LimDarren Jun Hao TanDouglas CheeKewin Tien Ho SiahYujun WongApichat KaewdechKarn WijarnpreechaAnand V KulkarniBenjamin NahDaniel Q HuangMazen NoureddinCheng-Han NgMargaret Teng

Published in: Digestive diseases and sciences (2023)

PPIs should be reserved for appropriate indications at lowest effective dose for cirrhotic patients due to the potential harm.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
cardiovascular events
cardiovascular disease
cross sectional
coronary artery disease